NEWFX
Price
$78.05
Change
+$0.52 (+0.67%)
Updated
Dec 23 closing price
RNWFX
Price
$78.24
Change
+$0.52 (+0.67%)
Updated
Dec 23 closing price
Ad is loading...

NEWFX vs RNWFX

Header iconNEWFX vs RNWFX Comparison
Open Charts NEWFX vs RNWFXBanner chart's image
American Funds New World A
Price$78.05
Change+$0.52 (+0.67%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$78.24
Change+$0.52 (+0.67%)
VolumeN/A
CapitalizationN/A
NEWFX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NEWFX vs. RNWFX commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEWFX is a Buy and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
NEWFX (62.2B) and RNWFX (62.2B) have equal amount of cash in the bank . RNWFX pays higher dividends than NEWFX: RNWFX (1.51) vs NEWFX (1.16). NEWFX was incepted earlier than RNWFX: NEWFX (26 years) vs RNWFX (23 years). NEWFX (32.00) and RNWFX (32.00) have comparable annual turnover. NEWFX (250) and RNWFX (250) have matching initial minimum investment requirements. RNWFX annual gain was more profitable for investors over the last year : 5.86 vs. NEWFX (5.47). RNWFX return over 5 years is better than : 14.39 vs. NEWFX (13.10).
NEWFXRNWFXNEWFX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence26 years23 years-
Gain YTD4.1784.54992%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRA250N/A-
Net Assets62.2B62.2B100%
Annual Yield % from dividends1.161.5177%
Returns for 1 year5.475.8693%
Returns for 3 years-5.78-5.10113%
Returns for 5 years13.1014.3991%
Returns for 10 years40.9842.6796%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VTRS12.520.39
+3.22%
Viatris
TEO11.890.14
+1.19%
Telecom Argentina SA
DX12.570.14
+1.13%
Dynex Capital
INTT7.680.04
+0.52%
inTEST Corp
VIRX0.21N/A
-1.87%
Viracta Therapeutics